In advanced tumours, TGF‐β transforms into a pro‐cancer factor through pathways such as AKT and C‐jun/SMAD3, further promoting angiogenesis, immune evasion and activation of Cancer‐Associated Fibroblasts (CAFs). Here, SMAD3 is linked to cancer.